Editorial
doi: 10.1097/QAD.0b013e3282f51922.
4E10 and 2F5 monoclonal antibodies: binding specificities to phospholipids, tolerance, and clinical safety issues
- PMID: 18317008
- DOI: 10.1097/QAD.0b013e3282f51922
Item in Clipboard
Editorial
4E10 and 2F5 monoclonal antibodies: binding specificities to phospholipids, tolerance, and clinical safety issues
AIDS.
.
No abstract available
Comment on
-
Difficulties in eliciting broadly neutralizing anti-HIV antibodies are not explained by cardiolipin autoreactivity.AIDS. 2007 Oct 18;21(16):2131-9. doi: 10.1097/QAD.0b013e3282a4a632. AIDS. 2007. PMID: 18090039
-
Reassessment of autoreactivity of the broadly neutralizing HIV antibodies 4E10 and 2F5 and retrospective analysis of clinical safety data.AIDS. 2007 Oct 18;21(16):2161-70. doi: 10.1097/QAD.0b013e328285da15. AIDS. 2007. PMID: 18090042
Similar articles
-
Difficulties in eliciting broadly neutralizing anti-HIV antibodies are not explained by cardiolipin autoreactivity.AIDS. 2007 Oct 18;21(16):2131-9. doi: 10.1097/QAD.0b013e3282a4a632. AIDS. 2007. PMID: 18090039
-
Interactions of HIV-1 antibodies 2F5 and 4E10 with a gp41 epitope prebound to host and viral membrane model systems.Chembiochem. 2009 Apr 17;10(6):1032-44. doi: 10.1002/cbic.200800609. Chembiochem. 2009. PMID: 19283693
-
Immunology. Close to the edge: neutralizing the HIV-1 envelope.Science. 2005 Jun 24;308(5730):1878-9. doi: 10.1126/science.1114854. Science. 2005. PMID: 15976295 No abstract available.
-
Introduction: HIV neutralizing antibodies: relevance to pathogenesis and vaccines.J Intern Med. 2007 Jul;262(1):2-4. doi: 10.1111/j.1365-2796.2007.01835.x. J Intern Med. 2007. PMID: 17598811 Review. No abstract available.
-
Immunology of HIV--filling in the details.Int J STD AIDS. 2004 Sep;15(9):574-82, quiz 583. doi: 10.1258/0956462041724217. Int J STD AIDS. 2004. PMID: 15339362 Review. No abstract available.
Cited by
-
Recognition of membrane-bound fusion-peptide/MPER complexes by the HIV-1 neutralizing 2F5 antibody: implications for anti-2F5 immunogenicity.PLoS One. 2012;7(12):e52740. doi: 10.1371/journal.pone.0052740. Epub 2012 Dec 21. PLoS One. 2012. PMID: 23285173 Free PMC article.
-
Vaccine-Elicited Tier 2 HIV-1 Neutralizing Antibodies Bind to Quaternary Epitopes Involving Glycan-Deficient Patches Proximal to the CD4 Binding Site.PLoS Pathog. 2015 May 29;11(5):e1004932. doi: 10.1371/journal.ppat.1004932. eCollection 2015 May. PLoS Pathog. 2015. PMID: 26023780 Free PMC article.
-
Cholesterol-dependent membrane fusion induced by the gp41 membrane-proximal external region-transmembrane domain connection suggests a mechanism for broad HIV-1 neutralization.J Virol. 2014 Nov;88(22):13367-77. doi: 10.1128/JVI.02151-14. Epub 2014 Sep 10. J Virol. 2014. PMID: 25210180 Free PMC article.
-
Effects of partially dismantling the CD4 binding site glycan fence of HIV-1 Envelope glycoprotein trimers on neutralizing antibody induction.Virology. 2017 May;505:193-209. doi: 10.1016/j.virol.2017.02.024. Epub 2017 Mar 6. Virology. 2017. PMID: 28279830 Free PMC article.
-
Peripheral Membrane Interactions Boost the Engagement by an Anti-HIV-1 Broadly Neutralizing Antibody.J Biol Chem. 2017 Mar 31;292(13):5571-5583. doi: 10.1074/jbc.M117.775429. Epub 2017 Feb 17. J Biol Chem. 2017. PMID: 28213514 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
